These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10754294)

  • 1. The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells.
    Braun SE; Chen K; Foster RG; Kim CH; Hromas R; Kaplan MH; Broxmeyer HE; Cornetta K
    J Immunol; 2000 Apr; 164(8):4025-31. PubMed ID: 10754294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action.
    Braun SE; Chen K; Blazar BR; Orchard PJ; Sledge G; Robertson MJ; Broxmeyer HE; Cornetta K
    Hum Gene Ther; 1999 Sep; 10(13):2141-51. PubMed ID: 10498246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model.
    Chen K; Braun S; Lyman S; Fan Y; Traycoff CM; Wiebke EA; Gaddy J; Sledge G; Broxmeyer HE; Cornetta K
    Cancer Res; 1997 Aug; 57(16):3511-6. PubMed ID: 9270021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells.
    Kim CH; Pelus LM; White JR; Applebaum E; Johanson K; Broxmeyer HE
    J Immunol; 1998 Mar; 160(5):2418-24. PubMed ID: 9498785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes.
    Nomura T; Hasegawa H; Kohno M; Sasaki M; Fujita S
    Int J Cancer; 2001 Mar; 91(5):597-606. PubMed ID: 11267967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.
    Hillinger S; Yang SC; Zhu L; Huang M; Duckett R; Atianzar K; Batra RK; Strieter RM; Dubinett SM; Sharma S
    J Immunol; 2003 Dec; 171(12):6457-65. PubMed ID: 14662845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
    Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
    J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.
    Giovarelli M; Cappello P; Forni G; Salcedo T; Moore PA; LeFleur DW; Nardelli B; Di Carlo E; Lollini PL; Ruben S; Ullrich S; Garotta G; Musiani P
    J Immunol; 2000 Mar; 164(6):3200-6. PubMed ID: 10706711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.
    Vicari AP; Ait-Yahia S; Chemin K; Mueller A; Zlotnik A; Caux C
    J Immunol; 2000 Aug; 165(4):1992-2000. PubMed ID: 10925282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
    Khoo NK; Chan FP; Saarloos MN; Lala PK
    Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
    Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
    Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
    Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
    Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration.
    Lavergne E; Combadière C; Iga M; Boissonnas A; Bonduelle O; Maho M; Debré P; Combadiere B
    J Immunol; 2004 Sep; 173(6):3755-62. PubMed ID: 15356122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
    Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
    J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
    J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
    Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
    Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.